Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients

Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN, Oct. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in structural heart therapi... Devices, Interventional, Cardiology Medtronic, transcatheter aortic valve replacement
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news